Discontinued — last reported Q2 '23
Business Segments · Goodwill, Acquired During Period
Pharmaceutical — Goodwill, Acquired During Period
Year-over-year, this metric declined by 100.0%, from $3.50M to $0.00. Over 2 years (FY 2021 to FY 2023), Pharmaceutical — Goodwill, Acquired During Period shows a downward trend with a -100.0% CAGR.
Analysis
StatementSegment
CategoryGrowth
SignalContext dependent
VolatilityVolatile
First reportedQ3 2014
Last reportedQ2 2023
How to read this metric
An increase indicates active M&A activity, while zero values suggest a focus on organic growth or a lack of recent acquisitions.
Detailed definition
The value of goodwill recognized on the balance sheet resulting from business acquisitions completed within the reportin...
Peer comparison
Used by investors to track inorganic growth strategies and the cost of market consolidation.
Metric ID:
cah_segment_pharmaceutical_goodwill_acquired_during_periodHistorical Data
3 years
| FY'21 | FY'22 | FY'23 | |
|---|---|---|---|
| Value | $2.00M | $14.00M | $0.00 |
| YoY Change | — | +600.0% | -100.0% |
Range$0.00 – $14.00M
CAGR-100.0%
Avg YoY Growth+250.0%
Median YoY Growth+250.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Cardinal Health's pharmaceutical — goodwill, acquired during period?
- Cardinal Health (CAH) reported pharmaceutical — goodwill, acquired during period of $0.00 in Q2 2023.
- How has Cardinal Health's pharmaceutical — goodwill, acquired during period changed year-over-year?
- Cardinal Health's pharmaceutical — goodwill, acquired during period decreased by 100.0% year-over-year, from $3.50M to $0.00.
- What is the long-term trend for Cardinal Health's pharmaceutical — goodwill, acquired during period?
- Over 2 years (2021 to 2023), Cardinal Health's pharmaceutical — goodwill, acquired during period has grown at a -100.0% compound annual growth rate (CAGR), from $2.00M to $0.00.
- What does pharmaceutical — goodwill, acquired during period mean?
- The amount of goodwill added to the segment's balance sheet from new acquisitions during the year.